- Home
- ZCMD vs DYAI Comparison
ZCMD vs DYAI Comparison
Compare ZCMD & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- DYAI
- Stock Information
- Founded
- ZCMD 2012
- DYAI 1979
- Country
- ZCMD China
- DYAI United States
- Employees
- ZCMD N/A
- DYAI N/A
- Industry
- ZCMD Other Consumer Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZCMD Real Estate
- DYAI Health Care
- Exchange
- ZCMD Nasdaq
- DYAI Nasdaq
- Market Cap
- ZCMD 28.5M
- DYAI 28.3M
- IPO Year
- ZCMD 2020
- DYAI 2004
- Fundamental
- Price
- ZCMD $1.10
- DYAI $1.00
- Analyst Decision
- ZCMD
- DYAI Strong Buy
- Analyst Count
- ZCMD 0
- DYAI 1
- Target Price
- ZCMD N/A
- DYAI $6.00
- AVG Volume (30 Days)
- ZCMD 241.3K
- DYAI 63.2K
- Earning Date
- ZCMD 01-01-0001
- DYAI 08-12-2025
- Dividend Yield
- ZCMD N/A
- DYAI N/A
- EPS Growth
- ZCMD N/A
- DYAI N/A
- EPS
- ZCMD N/A
- DYAI N/A
- Revenue
- ZCMD $15,864,773.00
- DYAI $3,554,344.00
- Revenue This Year
- ZCMD N/A
- DYAI $22.56
- Revenue Next Year
- ZCMD N/A
- DYAI $30.95
- P/E Ratio
- ZCMD N/A
- DYAI N/A
- Revenue Growth
- ZCMD N/A
- DYAI 57.59
- 52 Week Low
- ZCMD $0.95
- DYAI $0.91
- 52 Week High
- ZCMD $2.97
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- ZCMD 47.03
- DYAI 46.85
- Support Level
- ZCMD $1.10
- DYAI $0.91
- Resistance Level
- ZCMD $1.24
- DYAI $1.02
- Average True Range (ATR)
- ZCMD 0.08
- DYAI 0.05
- MACD
- ZCMD -0.01
- DYAI 0.01
- Stochastic Oscillator
- ZCMD 14.93
- DYAI 35.07
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.